Daryl Drummond
Chief Scientific Officer Akagera Medicines
Seminars
Thursday 1st October 2026
Panel Discussion: De-Risking CDMO Partnerships for mRNA: Building Scalable, Flexible & Future-Proof Manufacturing Strategies
10:10 am
Key questions include:
- How do you structure CDMO partnerships to balance speed, flexibility, and risk without overcomplicating your manufacturing network?
- What are the biggest misalignments between biopharma and CDMOs during scale-up – and how can they be avoided early?
- At what point should companies start designing for commercial-scale manufacturing, and how does that shape CDMO and supply chain decisions?
Wednesday 30th September 2026
Engineering Targeted LNP Platforms for Scalable & Accessible mRNA Vaccine Development
11:30 am
- Exploring formulation strategies for incorporating targeting moieties into lipid nanoparticle platforms to enhance dendritic cell uptake and improve vaccine potency at lower doses
- Sharing stability optimization approaches for targeted LNP systems, including considerations around lipid degradation, storage stability, and formulation robustness during development
- Discussing how early CMC and manufacturing decisions can support scalable, cost-effective mRNA vaccine production for global access and deployment in low-resource settings
